ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,085, issued on July 28, was assigned to OSARTIS GmbH (Muenster, Germany).

"Cancer treatment composition and method" was invented by Matthew Myntti (St. Augustine, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for selectively or preferentially reducing the amount of Fe ions available to cancer cells involves introducing to an area of the body which contains cancer cells an effective amount of an aqueous, pH buffered composition that includes dissociation products of a soluble weak acid and a salt of a weak acid. When the amount of arriving Fe ions falls below a first threshold, the cancer cell no longer can proliferate. When the amount...